Master Degree in Pharmaceutical Sciences First-class with GPAT qualification Preferably in Pharmaceutics from a recognized University. developing nanoformulations, mammalian cell cultures, and in vivo experiments. Synthesis of Polymers, peptides Characterization of physicochemical Parameter, Determination of anticancer therapeutic effect in the in vitro assay systems, Validation of the in vitro results in the in vivo animal models of tumor-bearing mice model and infectious disease models
M.Sc, BTech in Bio, Chemo, Pharmaco-informatics from a recognised university or Research experience in computational drug discovery. Knowledge of AI/ML would be an added advantage.
Graduate in Science, relevant subjects from a Consolidated recognized university with 3 years of work experience from a recognized institution or master's degree in the relevant subject or Pharm.D Doctor of Pharmacy from a recognized institution.
National Institute For Plant Biotechnology has been entrusted with the responsibility of developing new tools and techniques and to deliver breakthrough in biotechnology for crop improvement. With a humble beginning and a few dedicated scientists, the centre could successfully deliver varieties such as Pusa Jai Kisan, which is one of the top three mustard varieties released by the ICAR till date.
Gland Pharma is the worlds leading player in Injectables Formulation and Manufacturing. It is also into API and Intermediates research and manufacturing. Gland Pharma is present in sterile injectables, oncology and ophthalmic segments, and focus on complex injectables including NCE-1s, First-to-File products and 505b2 filings.
Post : Research Associate / Senior Research Associate
M. Pharm M.S. in Natural Products. Pharmaceutical Chemistry, Medicinal Chemistry or equivalent degree from a recognized University or equivalent. or M.Sc. in Organic Analytical Chemistry. Phytopharmaceutical Mission Phase III
Compile registration dossiers for submission to various health authorities like – US, Canada, Europe, Australia. Prepare responses to deficiency letters received from various agencies.